tiprankstipranks
M&A News: Paychex (NASDAQ:PAYX) Will Acquire PYCR for $4.1B
Market News

M&A News: Paychex (NASDAQ:PAYX) Will Acquire PYCR for $4.1B

Story Highlights

Paychex announced on Tuesday that it will acquire Paycor for $4.1 billion.

Paychex (PAYX) announced on Tuesday that it will acquire Paycor HCM (PYCR) in an all-cash deal worth $4.1 billion. The deal values Paycor at $22.50 per share and marks a premium of 19% over its 30-day volume-weighted average trading price as of January 3. Paychex is a provider of human capital management (HCM) software.

Stay Ahead of the Market:

The acquisition is expected to close in the first half of this year, subject to regulatory approvals and customary closing conditions.

Paychex’s Strategic Rationale Behind the Acquisition

Following the close of the deal, the combined entity will offer one of the most comprehensive HCM solution suites in the industry, catering to organizations of all sizes. This deal is also likely to extend Paychex’s upmarket position by expanding its portfolio of AI-driven HR technology and advisory services.

PAYX’s Expects the Acquisition to Be Accretive

Paychex projects the acquisition to be neutral to slightly accretive to adjusted diluted earnings per share (EPS) in the first Fiscal year following the close of the deal and accretive in the second FIscal year and beyond. By integrating Paycor’s talent software and payroll expertise, Paychex aims to enhance its offerings in HR management, employee benefits, insurance, and payroll solutions.

Is Paychex a Good Stock to Buy?

Analysts remain sidelined about PAYX stock, with a Hold consensus rating based on 10 Holds and two Sells. Over the past year, PAYX has increased by more than 20%, and the average PAYX price target of $138.17 implies a downside potential of 1.2% from current levels.

See more PAYX analyst ratings

Related Articles
TheFlyAsure Software price target raised to $14 from $12.50 at Northland
TipRanks Auto-Generated NewsdeskPaychex Acquires Paycor HCM for $4.1 Billion
TheFlyPaycor HCM downgraded to Hold from Buy at Needham
Go Ad-Free with Our App